Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.630
+0.003 (0.21%)
Aug 29, 2025, 11:28 AM EDT
Nuo Therapeutics Company Description
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.
The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market.
It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds.
The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014.
Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Nuo Therapeutics, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | David Jorden |
Contact Details
Address: 8285 El Rio Houston, Delaware 77054 United States | |
| Phone | (346) 396-4770 |
| Website | nuot.com |
Stock Details
| Ticker Symbol | AURX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US67059V2097 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| David E. Jorden CPA | Chief Executive Officer, Chief Financial Officer, Secretary and Executive Director |
| Dr. Peter Anton Clausen Ph.D. | Chief Operating Officer and Chief Scientific Officer |
| Joseph A. Del Guercio | Informal Board Advisor |